Skip Main Navigation Links Jump to Footer
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Hirsch E.C., Hunot S.
(2009)  The Lancet Neurology,  8  (4) , pp. 382-397.
x

You are in Preview mode, only the first 20 documents are visible.

Refine result list

Document Result List
Result Number Document title Authors Year Source Cited by
Inhibition of activated astrocyte ameliorates lipopolysaccharide- induced depressive-like behaviors 
Wang, Y., Ni, J., Zhai, L., (...), Zhao, L., Yin, X. 2019 Journal of Affective Disorders
0
Preclinical study of ibuprofen loaded transnasal mucoadhesive microemulsion for neuroprotective effect in MPTP mice model 
Mandal, S., Das Mandal, S., Chuttani, K., Sawant, K.K., Subudhi, B.B. 2018 Iranian Journal of Pharmaceutical Research
0
TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons 
Open Access
Maatouk, L., Compagnion, A.-C., Sauvage, M.-A.C.-D., (...), Manoury, B., Vyas, S. 2018 Nature Communications
0
MPP+decreases store-operated calcium entry and TRPC1 expression in Mesenchymal Stem Cell derived dopaminergic neurons 
Open Access
Sun, Y., Selvaraj, S., Pandey, S., (...), Singh, B.B., Ohm, J.E. 2018 Scientific Reports
0
Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice 
Yao, K., Zhao, Y.-F. 2018 Experimental Gerontology
0
Inhibition of Cyclooxygenase-2 (COX-2) Initiates Autophagy and Potentiates MPTP-Induced Autophagic Cell Death of Human Neuroblastoma Cells, SH-SY5Y: an Inside in the Pathology of Parkinson’s Disease 
Niranjan, R., Mishra, K.P., Thakur, A.K. 2018 Molecular Neurobiology
1
Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease 
Bortolanza, M., Nascimento, G.C., Socias, S.B., (...), Raisman-Vozari, R., Del-Bel, E. 2018 Journal of Neural Transmission
0
Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies 
Lim, S., Kim, H.-J., Kim, D.-K., Lee, S.-J. 2018 Progress in Neurobiology
0
Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies 
Gupta, N., Shyamasundar, S., Patnala, R., (...), Ling, E.-A., Dheen, S.T. 2018 Expert Opinion on Therapeutic Targets
0
Cerebrospinal Fluid C-Reactive Protein in Parkinson’s Disease: Associations with Motor and Non-motor Symptoms 
Sanjari Moghaddam, H., Valitabar, Z., Ashraf-Ganjouei, A., (...), Ghazi Sherbaf, F., Aarabi, M.H. 2018 NeuroMolecular Medicine
0
Analysis of neurotrophic and antioxidant factors related to midbrain dopamine neuronal loss and brain inflammation in the cerebrospinal fluid of the elderly 
Martin-de-Pablos, A., Córdoba-Fernández, A., Fernández-Espejo, E. 2018 Experimental Gerontology
1
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease 
Williams, G.P., Schonhoff, A.M., Jurkuvenaite, A., (...), Standaert, D.G., Harms, A.S. 2018 Journal of Neuroinflammation
0
NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease 
Cheng, L., Chen, L., Wei, X., (...), Gao, C., Liu, H. 2018 Journal of Neuroinflammation
0
A lincRNA-p21/miR-181 family feedback loop regulates microglial activation during systemic LPS- and MPTP- induced neuroinflammation 
Open Access
Ye, Y., He, X., Lu, F., (...), Lu, G., Zhang, S. 2018 Cell Death and Disease
0
Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop 
Open Access
Mouton-Liger, F., Rosazza, T., Sepulveda-Diaz, J., (...), Corvol, J.-C., Corti, O. 2018 GLIA
0
Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling 
L'Episcopo, F., Tirolo, C., Peruzzotti-Jametti, L., (...), Pluchino, S., Marchetti, B. 2018 Stem Cells
2
Inhibition of PP2A by hesperetin may contribute to Akt and ERK1/2 activation status in cortical neurons 
Vauzour, D., Corsini, S., Müller, M., Spencer, J.P.E. 2018 Archives of Biochemistry and Biophysics
2
Association of thiazolidinedione with a lower risk of Parkinson’s disease in a population with newly-diagnosed diabetes mellitus 
Lin, H.-L., Lin, H.-C., Tseng, Y.-F., Chao, J.C.-J., Hsu, C.-Y. 2018 Annals of Medicine
0
DNMT1 regulates expression of MHC class i in post-mitotic neurons 
Gustafsson, J.R., Katsioudi, G., Degn, M., (...), Issazadeh-Navikas, S., Kornum, B.R. 2018 Molecular Brain
0
Immunosuppressants and risk of Parkinson disease 
Open Access
Racette, B.A., Gross, A., Vouri, S.M., (...), Willis, A.W., Searles Nielsen, S. 2018 Annals of Clinical and Translational Neurology
0